NewAmsterdam Pharma shares dip on pricing upsized secondary stock offering at $11.50/share
- NewAmsterdam Pharma (NASDAQ:NAMS) shares slumps 11.14% after-hours on Tuesday after pricing an upsized public offering from its previously announced offer of 13.86M shares of the company’s ordinary shares, by selling shareholders at a public offering price of $11.50/share.
- Underwriters are granted a 30-day option to purchase up to an additional 2.08M ordinary shares at the public offering price.
- The Company will not receive any proceeds from the offering.
- Offering is expected to close on or about June 9, 2023.